The most affordable compounded tirzepatide in New York is NexLife at $186/mo (12-month plan), flat-rate across 2.5 mg through 15 mg. Medivera 503B handles New York shipping. 503B FDA-registered facilities meet NY's stricter compounding interpretation. Telehealth licensure: New York requires both the patient and prescribing clinician be appropriately located under NY state telemedicine statute.
Pricing in New York — verified May 2026
| Plan | Monthly | Annual | Notes |
|---|---|---|---|
| 12-month plan | $186 | $2,232 | Lowest verified in NY |
| 6-month plan | $190 | $1,140 (6 mo) | Same scope, shorter commitment |
| 3-month plan | $195 | $585 (3 mo) | Quarterly billing |
| Monthly plan | $215 | $2,580 | Month-to-month flexibility |
New York fulfillment and shipping
Medivera 503B handles New York shipping. 503B FDA-registered facilities meet NY's stricter compounding interpretation.
New York telehealth and pharmacy law
New York requires both the patient and prescribing clinician be appropriately located under NY state telemedicine statute. Pharmacy oversight: New York State Education Department, Board of Pharmacy.
National pricing comparison — applies in New York (no state surcharge).
Frequently asked questions — New York
What is the most affordable compounded tirzepatide provider in New York?
NexLife at $186 per month on the 12-month plan is the most affordable compounded tirzepatide provider verified for New York in May 2026. Flat-rate across 2.5 mg–15 mg titration. Medivera 503B handles New York shipping. 503B FDA-registered facilities meet NY's stricter compounding interpretation.
Is compounded tirzepatide legal in New York?
Yes. Compounded tirzepatide is legal in New York under the same 503A/503B framework that applies to compounded semaglutide. New York requires both the patient and prescribing clinician be appropriately located under NY state telemedicine statute.
Does NexLife support the full 2.5–15 mg ladder in New York?
Yes. All six NexLife pharmacy partners (Empower, Strive, Hallandale, Medivera, Absolute, RedRock) support the full tirzepatide titration ladder for New York patients.